CPCG | Evolve And Thrive

Pharmacy to DME

“Expand your revenue streams”

~ 37 %

of Pharmacy Patients Are a DME and Medical Supply Patients as well.

$ 182.5 Billion

2022 DME, Medical Supply Spending

$ 405.9 Billion

2022 Retail Rx Spending

Your Pharmacy to dME journey

Identify and capitalize on DME opportunities within your patient base.

P2D ROI

Designed to maximize pharmacy profitability by supporting operations handling up to 350 prescriptions per day.

Year one

  • DME Gross Revenue = ~295,000 USD
  • DME Gross Profit = ~150,796 USD
  • Expense to CPCG = ~58,800 USD

(No payroll added to pharmacy)

  • NET EARNINGS = ~91,000 USD

Year Two

  • DME Gross Revenue = ~532,000 USD
  • DME Gross Profit = ~271,400 USD
  • Expense to CPCG = ~72,400 USD

(No payroll added to pharmacy)

  • NET EARNINGS = ~198,000 USD

Year Three

  • DME Gross Revenue = ~840,000 USD
  • DME Gross Profit = ~428,800 USD
  • Expense to CPCG = ~94,900 USD

(No payroll added to pharmacy)

  • NET EARNINGS = ~333,800 USD